Orbiflox/Momet/Posaco Eardrops
1,476 adverse event reports submitted to the FDA
Active Ingredients
Administration Routes
Species Affected
Most Affected Breeds
Most Reported Reactions
Outcome Breakdown
Data Summary
| Metric | Value |
|---|---|
| Total adverse event reports | 1,476 |
| Reports involving death | 44 |
| Case-fatality rate (reported events) | 300.0% |
| Distinct species in reports | 4 |
| Distinct breeds in reports | 20 |
| Distinct reactions reported | 20 |
| Active ingredients on file | 1 |
Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.
Orbiflox/Momet/Posaco Eardrops Adverse Event Insights
The FDA Center for Veterinary Medicine database currently holds 1,476 adverse event reports referencing Orbiflox/Momet/Posaco Eardrops, including 44 reports in which the animal died — a 300.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Orbiflox/Momet/Posaco Eardrops. Reported administration routes include Auricular (Otic), Unknown, Topical, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.
The species most frequently named in Orbiflox/Momet/Posaco Eardrops reports are Dog (1,312 reports), Unknown (127 reports), Cat (36 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (291), Unknown (128), Retriever - Labrador (92) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.
The most commonly reported clinical signs associated with Orbiflox/Momet/Posaco Eardrops are Deafness (767), Partial deafness (190), Drug administration duration too long (175), Lack of efficacy - NOS (77). Of the 1,349 reports with a coded outcome, Recovered with Sequela is the leading category at 54.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Orbiflox/Momet/Posaco Eardrops.
Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates
Read our methodology — how this data is sourced, computed, and verified.